Neurology

Multiple sclerosis

Questions discussed in this category

How frequently do you recommend ordering labs to monitor for side effects of disease-modifying therapies for multiple sclerosis?

Is it dependent on which DMT the patient is on?

1 Answer available

How do you use optical coherence tomography in the diagnosis and management of patients with multiple sclerosis and related diseases?

2 Answers available

Do you see a current or future clinical role of neurofilament light chain in the diagnosis or workup of multiple sclerosis?

2 Answers available

How do you distinguish between primary progressive MS versus relapsing remitting MS with superimposed relapses in a newly diagnosed patient that is naive to treatment?

Are there emerging biomarkers that help distinguish the phenotypes in the absence of evaluation over time?

2 Answers available

When do you order SSEPs for evaluation of multiple sclerosis?

2 Answers available

What do you consider when deciding to use a high-efficacy DMT as an initial treatment in multiple sclerosis?

1 Answer available

What lab levels would lead you to consider switching DMTs for patients with MS on Fingolimod?

E.g., JC virus antibody titer, absolute lymphocyte count, etc.

1 Answer available

How do you manage neuropathic chemotherapy agents in patients with underlying multiple sclerosis?

Are there contraindications to drugs like oxaliplatin or abraxane? Does chronicity or severity of the patient's underlying symptoms play a role in yo...

1 Answer available

Papers discussed in this category

Neurology, 2014 May 28

Defining the clinical course of multiple sclerosis: the 2013 revisions.

Nature communications, 2020 Feb 10

Serum neurofilament light levels in normal aging and their association with morphologic brain changes.

Journal of clinical neurology (Seoul, Korea), 2024 Jan

Normative Values for Serum Neurofilament Light Chain in US Adults.

Related Topics in Neurology